Current and Future Prospects for Epigenetic Biomarkers of Substance Use Disorders - PubMed (original) (raw)

Review

Current and Future Prospects for Epigenetic Biomarkers of Substance Use Disorders

Allan M Andersen et al. Genes (Basel). 2015.

Abstract

Substance abuse has an enormous impact on economic and quality of life measures throughout the world. In more developed countries, overutilization of the most common forms of substances of abuse, alcohol and tobacco, is addressed primarily through prevention of substance use initiation and secondarily through the treatment of those with substance abuse or dependence. In general, these therapeutic approaches to substance abuse are deemed effective. However, there is a broad consensus that the development of additional tools to aid diagnosis, prioritize treatment selection and monitor treatment response could have substantial impact on the effectiveness of both substance use prevention and treatment. The recent demonstrations by a number of groups that substance use exposure is associated with robust changes in DNA methylation signatures of peripheral blood cells suggests the possibility that methylation assessments of blood or saliva could find broad clinical applications. In this article, we review recent progress in epigenetic approaches to substance use assessment with a particular emphasis on smoking (and alcohol) related applications. In addition, we highlight areas, such as the epigenetics of psychostimulant, opioid and cannabis abuse, which are markedly understudied and could benefit from intensified collaborative efforts to define epigenetic biomarkers of abuse and dependence.

Keywords: addiction; alcohol; biomarkers; cannabis; epigenetics; opioids; psychostimulants; smoking; substance use disorders; tobacco.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Global disability-adjusted life years (DALYs) annually by risk factor.

Figure 2

Figure 2

Global deaths annually by risk factor.

Similar articles

Cited by

References

    1. Institute for Health Metrics and Evaluation (IHME) GBD Compare. [(accessed on 17 June 2015)]. Available online: http://vizhub.healthdata.org/gbd-compare.
    1. Centers for Disease Control and Prevention (CDC) Vital signs: Current cigarette smoking among adults aged 18 ≥ years—United States, 2005–2010. Morbidity Mortality Weekly Rep. 2011;60:1207–1212. - PubMed
    1. Bouchery E.E., Harwood H.J., Sacks J.J., Simon C.J., Brewer R.D. Economic costs of excessive alcohol consumption in the US, 2006. Am. J. Prev. Med. 2011;41:516–524. doi: 10.1016/j.amepre.2011.06.045. - DOI - PubMed
    1. US Department of Health and Human Services . Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Substance Abuse and Mental Health Services Administration; Rockville, MD, USA: 2011.
    1. Staines G.L., Magura S., Foote J., Deluca A., Kosanke N. Polysubstance use among alcoholics. J. Addict. Dis. 2001;20:57–73. doi: 10.1300/J069v20n04_06. - DOI - PubMed

Publication types

Grants and funding

LinkOut - more resources